Generali Investments Cee, Investicni Spolecnost, A.S. Astrazeneca PLC Transaction History
Generali Investments Cee, Investicni Spolecnost, A.S.
- $970 Billion
- Q4 2024
A detailed history of Generali Investments Cee, Investicni Spolecnost, A.S. transactions in Astrazeneca PLC stock. As of the latest transaction made, Generali Investments Cee, Investicni Spolecnost, A.S. holds 21,100 shares of AZN stock, worth $1.53 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
21,100Holding current value
$1.53 Million% of portfolio
0.14%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,339Shares Held
478MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.55 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$3.04 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.7 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.66 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.38 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $224B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...